Registration Strip Icon for monitor ブラジル証券取引所、NASDAQ、NYSE、AMEX、LSEなどの主要取引所からの複数のリアルタイム株価を監視します。

ATHX

Athersys (ATHX)

Athersys Inc
から:
次の項目別のソート:
 Showing the most relevant articles for your search:NASDAQ:ATHX
日付受信時刻ニュースソース見出しコード企業名
2024/01/0821 : 31Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:ATHXAthersys Inc
2023/12/2307 : 09Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:ATHXAthersys Inc
2023/12/2201 : 37Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ATHXAthersys Inc
2023/11/1622 : 35Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:ATHXAthersys Inc
2023/10/1821 : 00Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:ATHXAthersys Inc
2023/10/1705 : 52Business WireAthersys Extends Near Term Liquidity with Proceeds from Warrant Inducement and Global ARDS License with Healios to Explore Strategic AlternativesNASDAQ:ATHXAthersys Inc
2023/10/1222 : 28Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:ATHXAthersys Inc
2023/10/1122 : 27Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:ATHXAthersys Inc
2023/10/1021 : 30Business WireAthersys Reports Interim Analysis Results of MASTERS-2 Clinical Study with MultiStem in Ischemic Stroke, Signs Memorandum of Understanding (MOU) for Global ARDS License with HealiosNASDAQ:ATHXAthersys Inc
2023/10/0706 : 34Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ATHXAthersys Inc
2023/10/0706 : 28Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ATHXAthersys Inc
2023/10/0405 : 41Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:ATHXAthersys Inc
2023/10/0405 : 30Business WireAthersys Licenses its Animal Health Assets to Ardent Animal HealthNASDAQ:ATHXAthersys Inc
2023/10/0306 : 05Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:ATHXAthersys Inc
2023/10/0306 : 04Business WireAthersys Director Jane Wasman Appointed Board ChairNASDAQ:ATHXAthersys Inc
2023/09/2605 : 36Edgar (US Regulatory)Form 424B3 - Prospectus [Rule 424(b)(3)]NASDAQ:ATHXAthersys Inc
2023/09/2213 : 15Edgar (US Regulatory)Form EFFECT - Notice of EffectivenessNASDAQ:ATHXAthersys Inc
2023/09/2001 : 28Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ATHXAthersys Inc
2023/09/1910 : 35Edgar (US Regulatory)Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) materialNASDAQ:ATHXAthersys Inc
2023/09/1910 : 04Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:ATHXAthersys Inc
2023/09/1500 : 00Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ATHXAthersys Inc
2023/09/1423 : 41Edgar (US Regulatory)Form 3 - Initial statement of beneficial ownership of securitiesNASDAQ:ATHXAthersys Inc
2023/09/1406 : 13Edgar (US Regulatory)Form S-3 - Registration statement under Securities Act of 1933NASDAQ:ATHXAthersys Inc
2023/09/1121 : 46Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:ATHXAthersys Inc
2023/09/0703 : 45Business WireGrant Awarded to Newcastle University to Research Athersys’ MultiStem® in Machine Perfusion Prior to Kidney TransplantationNASDAQ:ATHXAthersys Inc
2023/08/2203 : 36Edgar (US Regulatory)Form 424B4 - Prospectus [Rule 424(b)(4)]NASDAQ:ATHXAthersys Inc
2023/08/1823 : 14Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:ATHXAthersys Inc
2023/08/1810 : 30Business WireAthersys, Inc. Announces Pricing of $3.5 Million Public OfferingNASDAQ:ATHXAthersys Inc
2023/08/1805 : 15Edgar (US Regulatory)Form DEF 14A - Other definitive proxy statementsNASDAQ:ATHXAthersys Inc
2023/08/1706 : 05Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:ATHXAthersys Inc
 Showing the most relevant articles for your search:NASDAQ:ATHX

最近閲覧した銘柄

Delayed Upgrade Clock